Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer T Donnem, SM Hald, EE Paulsen, E Richardsen, S Al-Saad, TK Kilvaer, ... Clinical Cancer Research 21 (11), 2635-2643, 2015 | 311 | 2015 |
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer T Donnem, TK Kilvaer, S Andersen, E Richardsen, EE Paulsen, SM Hald, ... Annals of oncology 27 (2), 225-232, 2016 | 185 | 2016 |
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups MLH Milo, BV Offersen, T Bechmann, ACP Diederichsen, CR Hansen, ... Radiotherapy and Oncology 150, 121-127, 2020 | 58 | 2020 |
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer M Rakaee, TK Kilvaer, S Jamaly, T Berg, EE Paulsen, M Berglund, ... British Journal of Cancer 124 (10), 1680-1689, 2021 | 56 | 2021 |
Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma MF Gjerstorff, M Pøhl, KE Olsen, HJ Ditzel BMC cancer 13, 1-6, 2013 | 44 | 2013 |
Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer KH Jensen, G Persson, AL Bondgaard, M Pøhl Acta Oncologica 57 (8), 1127-1128, 2018 | 42 | 2018 |
Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trial M Josipovic, MC Aznar, JB Thomsen, J Scherman, SMS Damkjaer, ... The British journal of radiology 92 (1104), 20190569, 2019 | 37 | 2019 |
Early appearance of coronavirus disease 2019 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer MH Suppli, SR de Blanck, T Elgaard, M Josipovic, M Pøhl Journal of Thoracic Oncology 15 (6), 1081-1084, 2020 | 32 | 2020 |
Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—Real world efficacy MT Mouritzen, A Carus, M Ladekarl, P Meldgaard, AWM Nielsen, ... Cancers 13 (19), 4846, 2021 | 25 | 2021 |
SSX2‐4 expression in early‐stage non‐small cell lung cancer KBV Greve, M Pøhl, KE Olsen, O Nielsen, HJ Ditzel, MF Gjerstorff Tissue antigens 83 (5), 344-349, 2014 | 23 | 2014 |
Tissue microarrays in non–small-cell lung cancer: reliability of immunohistochemically-determined biomarkers M Pøhl, KE Olsen, R Holst, HJ Ditzel, O Hansen Clinical lung cancer 15 (3), 222-230. e3, 2014 | 20 | 2014 |
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study MT Mouritzen, KF Junker, A Carus, M Ladekarl, P Meldgaard, ... Acta Oncologica 61 (4), 409-416, 2022 | 15 | 2022 |
Antineoplastic treatment with crizotinib during pregnancy: a case report KH Jensen, G Persson, L Storgaard, BB Nielsen, BW Pedersen, ... Acta Oncologica 58 (1), 121-122, 2019 | 12 | 2019 |
Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for … L Hoffmann, GF Persson, L Nygård, TB Nielsen, S Borrisova, ... Radiotherapy and Oncology 171, 53-61, 2022 | 11 | 2022 |
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC) J Dahlgaard, W Mazin, T Jensen, M Pøhl, W Bshara, A Hansen, E Kanisto, ... BMC research notes 4, 1-12, 2011 | 11 | 2011 |
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial M Rakaee, S Andersen, K Giannikou, EE Paulsen, TK Kilvær, ... Annals of Oncology 34 (7), 578-588, 2023 | 6 | 2023 |
An investigative expansion of a competing risk model for first failure site in locally advanced non-small cell lung cancer T Lacoppidan, IR Vogelius, M Pøhl, M Strange, GF Persson, L Nygård Acta Oncologica 58 (10), 1386-1392, 2019 | 6 | 2019 |
Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer M Pøhl, KE Olsen, R Holst, T Donnem, LT Busund, RM Bremnes, ... Acta Oncologica 55 (2), 167-177, 2016 | 6 | 2016 |
Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose–response studies L Stervik, N Pettersson, J Scherman, CF Behrens, C Ceberg, S Engelholm, ... Acta Oncologica 59 (6), 628-635, 2020 | 5 | 2020 |
Deep inspiration breath hold compliance in radiation therapy for locally advanced lung cancer GF Persson, MC Aznar, JS Rydhög, SR Mortensen, L Nygaard, M Pøhl, ... International Journal of Radiation Oncology, Biology, Physics 99 (2), E491, 2017 | 5 | 2017 |